Esquire Financial (ESQ) director reports restricted stock and options holdings

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. director reported acquiring 753 shares of restricted common stock on December 10, 2025 at a stated price of $0 per share. Following this grant, the director beneficially owns 72,401 shares of common stock directly.

The newly reported 753 restricted shares vest 100% on December 10, 2026. The total holding includes multiple prior restricted stock awards that vest in three equal annual installments beginning on December 19, 2023, December 9, 2025, December 19, 2026, December 3, 2027, and December 15, 2027. The director also holds fully vested stock options for 2,000 shares at $20.85 expiring December 16, 2030 and 1,750 shares at $31.04 expiring December 9, 2031.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Deutsch Todd

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		A		753(1)	A	$0	72,401(2)(3)(4)(5)(6)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$20.85							12/16/2021	12/16/2030	Common Stock	2,000(7)		2,000(7)	D
Stock Options	$31.04							12/09/2022	12/09/2031	Common Stock	1,750(7)		1,750(7)	D

Explanation of Responses:

1. Shares of restricted stock vest 100% on December 10, 2026.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

7. Stock options are fully vested.

	/s/ Eric S. Bader, pursuant to power of attorney	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Esquire Financial (ESQ) report on December 10, 2025?

The filing shows a director acquired 753 shares of Esquire Financial (ESQ) restricted common stock on December 10, 2025 at a stated price of $0 per share.

How many Esquire Financial (ESQ) shares does the director beneficially own after this transaction?

After the reported transaction, the director beneficially owns 72,401 shares of Esquire Financial (ESQ) common stock, held in direct ownership.

When do the newly acquired restricted Esquire Financial (ESQ) shares vest?

The 753 newly acquired restricted shares of Esquire Financial (ESQ) are scheduled to vest 100% on December 10, 2026.

What other restricted stock awards does the Esquire Financial (ESQ) director hold?

The director’s total includes restricted stock that vests in three equal annual installments starting on December 19, 2023, December 9, 2025, December 19, 2026, December 3, 2027, and December 15, 2027.

What stock options in Esquire Financial (ESQ) are reported as beneficially owned?

The director holds fully vested stock options for 2,000 shares at an exercise price of $20.85 expiring on December 16, 2030, and 1,750 shares at $31.04 expiring on December 9, 2031, each for Esquire Financial (ESQ) common stock.

Is the reported ownership in Esquire Financial (ESQ) held directly or indirectly?

The Form 4 indicates the 72,401 shares of Esquire Financial (ESQ) common stock are held in direct (D) ownership by the reporting person.